Open access
105
Views
18
CrossRef citations to date
0
Altmetric
Review
Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease – a network meta-analysis
Shannon Cope1 Mapi Values, Boston, MA, USA
, Gorana Capkun-Niggli2 Health Economics and Outcomes Research, Novartis Pharma AG, Basel, Switzerland
, Rupert Gale3 Novartis Horsham Research Centre, Horsham, UK
, José R Jardim4 Respiratory Division, Federal University of São Paulo, Brazil
& Jeroen P Jansen1 Mapi Values, Boston, MA, USACorrespondence[email protected]
Pages 329-344
|
Published online: 08 Jun 2011
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.